Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - Esperion Therapeutics, Inc. | a2234199zex-31_2.htm |
| EX-31.1 - EX-31.1 - Esperion Therapeutics, Inc. | a2234199zex-31_1.htm |
| EX-23.1 - EX-23.1 - Esperion Therapeutics, Inc. | a2234199zex-23_1.htm |
| 10-K - 10-K - Esperion Therapeutics, Inc. | a2234199z10-k.htm |
QuickLinks -- Click here to rapidly navigate through this document
CERTIFICATIONS UNDER SECTION 906
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Esperion Therapeutics, Inc., a Delaware corporation (the "Company"), does hereby certify, to such officer's knowledge, that:
The Annual Report for the year ended December 31, 2017 (the "Form 10-K") of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Dated: February 20, 2018 | /s/ TIM M. MAYLEBEN Tim M. Mayleben President and Chief Executive Officer (Principal Executive Officer) |
|
/s/ RICHARD B. BARTRAM Richard B. Bartram Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |
CERTIFICATIONS UNDER SECTION 906